Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3016 AL 3030

Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies

Dai L, Liu M, Ke W, Chen L, Fang X, Zhang Z.

Cell Mol Life Sci. 2024 Sep 3;81(1):382. doi: 10.1007/s00018-024-05419-5.

Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease

Bisht M, Kadian JP, Hooda T, Jain N, Lather A, Aggarwal N.

Drug Res (Stuttg). 2024 Oct;74(8):365-378. doi: 10.1055/a-2401-4578. Epub 2024 Oct 1.

Patient Empowerment for Those Living with Parkinson's Disease

Mathur S, Mathur S.

J Parkinsons Dis. 2024;14(s1):S173-S180. doi: 10.3233/JPD-230235.

Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

de Fátima Dos Santos Sampaio M, de Paiva YB, Sampaio TB, Pereira MG, Coimbra NC.

Basic Clin Pharmacol Toxicol. 2024 May;134(5):574-601. doi: 10.1111/bcpt.13997. Epub 2024 Mar 13.

Non-coding RNAs in Parkinson's disease: Regulating SNCA and alpha-synuclein aggregation

Thangavelu L, Moglad E, Afzal M, Almalki WH, Malathi H, Bansal P, Rani B, Walia C, Sivaprasad GV, Rajput P, Imran M.

Pathol Res Pract. 2024 Sep;261:155511. doi: 10.1016/j.prp.2024.155511. Epub 2024 Jul 30.

From mitochondrial dysfunction to neuroinflammation in Parkinson's disease: Pathogenesis and mitochondrial therapeutic approaches

Ebadpour N, Mahmoudi M, Kamal Kheder R, Abavisani M, Baridjavadi Z, Abdollahi N, Esmaeili SA.

Int Immunopharmacol. 2024 Dec 5;142(Pt A):113015. doi: 10.1016/j.intimp.2024.113015. Epub 2024 Sep 1.

Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias

Cooper O, Hallett P, Isacson O.

FEBS J. 2024 Feb;291(4):632-645. doi: 10.1111/febs.16638. Epub 2022 Oct 12.

mHealth-assisted expiratory muscle strength training in Parkinson's disease patients: A proof-of-concept study

Srp M, Ferro ÁS, Ferreira J, Cacho R, Antunes L, Bouça-Machado R, Gál O, Hoskovcová M, Kliment R, Mužík J, Mestre TA, Rangel DP, Růžička E, Consortium IP.

J Parkinsons Dis. 2024 Nov;14(8):1623-1630. doi: 10.1177/1877718X241296013. Epub 2025 Jan 14.

The Use of Focused Ultrasound Ablation for Movement Disorders

Silva N, Green M, Roque D, Krishna V.

Magn Reson Imaging Clin N Am. 2024 Nov;32(4):651-659. doi: 10.1016/j.mric.2024.04.003. Epub 2024 Jul 29.

Pink1/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats

Manganaro JE, Emanuel K, Lamberty BG, George JW, Stauch KL.

Res Sq [Preprint]. 2024 May 30:rs.3.rs-4431604. doi: 10.21203/rs.3.rs-4431604/v1.

α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in Mice

Morais LH, Boktor JC, MahmoudianDehkordi S, Kaddurah-Daouk R, Mazmanian SK.

bioRxiv [Preprint]. 2024 Jun 10:2024.06.07.597975. doi: 10.1101/2024.06.07.597975.

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4

Feringa FM, Hertog SJK, Wang L, Derks RJE, Kruijff I, Erlebach L, Heijneman J, Miramontes R, Pömpner N, Blomberg N, Olivier-Jimenez D, Johansen LE, Cammack AJ, Giblin A, Toomey CE, Rose IVL, Yuan H, Ward M, Isaacs AM, Kampmann M, Kronenberg-Versteeg D, Lashley T, Thompson LM, Ori A, Mohammed Y, Giera M, van der Kant R.

bioRxiv [Preprint]. 2024 Jul 3:2024.07.01.601474. doi: 10.1101/2024.07.01.601474.

Contrastive Graph Pooling for Explainable Classification of Brain Networks

Xu J, Bian Q, Li X, Zhang A, Ke Y, Qiao M, Zhang W, Sim WKJ, Gulyás B; Alzheimer’s Disease Neuroimaging Initiative.

ArXiv [Preprint]. 2024 Sep 6:arXiv:2307.11133v3.

Contribution of glutamatergic projections to neurons in the nonhuman primate lateral substantia nigra pars reticulata for the reactive inhibition

Yoshida A, Hikosaka O.

bioRxiv [Preprint]. 2024 Dec 25:2024.12.25.630331. doi: 10.1101/2024.12.25.630331.

Post-translational modification and mitochondrial function in Parkinson's disease

Luo S, Wang D, Zhang Z.

Front Mol Neurosci. 2024 Jan 11;16:1329554. doi: 10.3389/fnmol.2023.1329554. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias